The covered medications are: All formulations of Wegovy (semaglutide), including both the once-weekly injection and the once-daily oral 25 mg tablet approved by the FDA in December 2025 All formulations of Foundayo (orforglipron), which is an oral tablet The KwikPen formulation of Zepbound (tirzepatide, technically a dual GIP and GLP-1 receptor agonist) only The Zepbound autoinjector pen is not on the Bridge covered list
Bioinformatics 27 (21), 29572963
Full safety breakdown on Retatrutide for weight loss
From the corneas in your eyes to the marrow in your bones, collagen is the primary structural component
These effects were observed despite similar improvements in glycemic control measured by HbA1c reduction
28, Ahmed Sait Road, Bangalore, Urban, Bengaluru, Karnataka, 560005, India vitamin c tablets in Bengaluru Report incorrect details